UPMC Health Plan, a health plan owned by the University of Pittsburgh Medical Center, has launched a new social impact initiative to address social determinants of health and reduce health inequities in underserved communities.

Machine learning can play a key role in planning treatment for patients diagnosed with major depressive disorder (MDD), according to new research published in JAMA Network Open.

3Derm Systems, a Boston-based skin imaging and diagnostics company, has received two FDA Breakthrough Device designations for its 3DermSpot AI solution.

The patient is seeking class action status for the lawsuit to include other women who had breast scans during a two-year period at Raleigh Radiology Blue Ridge.

Blood pressure-monitoring technology is hitting the wearables market hard this year, and tech companies are vying to create the optimal tool for tracking BP on the go. But one company thinks they already have it figured out, according to CNET—in the form of BP-monitoring earbuds.

The Raleigh, North Carolina, company's growing team of providers now stretches across 13 states and 130 outpatient centers. 

She wants a refund following an FDA review, which determined that some imaging tests did not meet federal quality standards. 

Taking steps to keep older patients’ systolic blood pressure under the 120 mmHg mark could lower those patients’ risk of MI, stroke, death and mild cognitive impairment, according to a new study—but it could also fast-track a decline in kidney health.

A new robotic device is capable of helping people with spinal cord injuries (SCIs) sit more stably and comfortably, according to new research published in Spinal Cord Series and Cases.

Walgreens has hired Kevin Ban, MD, as its new chief medical officer, the company announced Jan. 6. Ban comes to Walgreens from Athenahealth, where he served as CMO.